E. P. Kwiatkowska-Borowczyk, “Adoptive transfer of tumor specific T cells from allogeneic donors is feasible, effective and safe alternative to autologous T cell based tumor immunotherapy”, JMS, vol. 83, no. 1, pp. 21–28, Mar. 2014.